Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
If you live in the La Luz De Sol area of Albuquerque, New Mexico, getting FDA-approved GLP-1 receptor agonist medications has never been simpler. Our straightforward telehealth platform removes every barrier — no confusing paperwork, no lengthy wait times, no complicated insurance pre-authorization for most patients in Bernalillo County. Just three clear steps from assessment to medication at your door.
GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescribed by NM-licensed doctors through a simple, jargon-free process designed specifically for Albuquerque residents who want effective care without the complexity.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 6, 2026
Ozempic (diabetes) and Wegovy (weight management). Once-weekly injection — simple to administer, simple to obtain online.
Mounjaro (diabetes) and Zepbound (weight loss). Dual-action GIP/GLP-1 — the most powerful option, just as easy to use as semaglutide.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to La Luz De Sol, Albuquerque residents:
Telehealth prescribing of GLP-1 receptor agonists in New Mexico is conducted by board-certified, NM-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Getting GLP-1 from La Luz De Sol is as simple as it gets — three clear steps, no complications, no wasted time. Everything happens from your home in Albuquerque with no trips to clinics or pharmacies required.
Answer a short, straightforward health questionnaire from your home in La Luz De Sol. Simple language, no medical jargon. Cover your basic health history, current medications, weight, and goals. The whole thing takes 2-3 minutes. That is it for step one.
A NM-licensed physician reviews your answers and conducts a simple telehealth consultation. They explain your options clearly, answer any questions, and issue your prescription without unnecessary complexity. Most patients find this the easiest medical consultation they have ever had.
Your GLP-1 medication ships directly to your La Luz De Sol address from a licensed US pharmacy. Most patients in Albuquerque receive their medication within 3-5 business days. No pharmacy lines, no picking up packages — just open the door and begin your treatment.
Our easy telehealth platform serves all neighborhoods in Albuquerque and surrounding areas with the same straightforward process.
Simple GLP-1 telehealth access across every neighborhood in Albuquerque, NM — no complications anywhere.
Also offering the same easy, no-complication GLP-1 access in cities near Albuquerque.
Easy, no-complication GLP-1 telehealth available in the largest cities across New Mexico.
Our easy, three-step telehealth platform brings straightforward GLP-1 access to the largest cities across the United States. Find simple, no-hassle care near you.
Local weight loss and GLP-1 providers serving the La Luz De Sol, Albuquerque area, based on Google Business listings.
4919 Prospect Ave NE, Albuquerque, NM 87110
5/5 ★ (89 reviews)
3840 Commons Ave NE Suite A, Albuquerque, NM 87109
5/5 ★ (29 reviews)
3200 Carlisle Blvd NE, Albuquerque, NM 87110
4.2/5 ★ (5 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Extremely simple. Residents of La Luz De Sol and greater Albuquerque, New Mexico complete just three steps: a 2-3 minute health questionnaire, a short telehealth consultation with a NM-licensed physician, and then wait for home delivery. That is the entire process from start to finish.
Very little. Patients in La Luz De Sol and throughout Albuquerque complete a straightforward digital health questionnaire — no complicated forms, no faxing documents to clinics. The entire process is managed online through a simple, intuitive platform.
Not at all. Everything on our Albuquerque platform is written in plain language. Your physician consultation is a friendly, jargon-free conversation. We make GLP-1 access simple for everyone, regardless of their medical background.
Yes, completely straightforward. Bernalillo County residents can access all FDA-approved GLP-1 medications — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) — through a simple three-step online process with no in-person visits required.
Simplicity and safety go hand in hand on our platform. All prescriptions are issued by board-certified, NM-licensed physicians through HIPAA-compliant telehealth platforms. We have made the process simple without cutting any corners on medical quality.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
